Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway

Simona Caporali; Ester Alvino; Adriana Amaro; Pedro Miguel Lacal; Lauretta Levati; Maria Grazia Atzori; Gian Carlo Antonini Cappellini; Federica Ruffini; Enzo Bonmassar; Ulrich Pfeffer; Stefania D'Atri

doi:10.1186/1479-5876-13-S1-P5

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway

Simona Caporali, Ester Alvino, Adriana Amaro, Pedro Miguel Lacal, Lauretta Levati, Maria Grazia Atzori, Gian Carlo Antonini Cappellini, Federica Ruffini, Enzo Bonmassar, Ulrich Pfeffer, Stefania D'Atri

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Journal of Translational Medicine
DOIs	https://doi.org/10.1186/1479-5876-13-S1-P5
Publication status	Accepted/In press - Jan 15 2015

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Medicine(all)

Access to Document

10.1186/1479-5876-13-S1-P5

Cite this

Caporali, S., Alvino, E., Amaro, A., Lacal, P. M., Levati, L., Atzori, M. G., Cappellini, G. C. A., Ruffini, F., Bonmassar, E., Pfeffer, U., & D'Atri, S. (Accepted/In press). Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway. Journal of Translational Medicine, 1-2. https://doi.org/10.1186/1479-5876-13-S1-P5

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway. / Caporali, Simona; Alvino, Ester; Amaro, Adriana et al.

In: Journal of Translational Medicine, 15.01.2015, p. 1-2.

Research output: Contribution to journal › Article › peer-review

Caporali, S, Alvino, E, Amaro, A, Lacal, PM, Levati, L, Atzori, MG, Cappellini, GCA, Ruffini, F, Bonmassar, E, Pfeffer, U & D'Atri, S 2015, 'Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway', Journal of Translational Medicine, pp. 1-2. https://doi.org/10.1186/1479-5876-13-S1-P5

Caporali S, Alvino E, Amaro A, Lacal PM, Levati L, Atzori MG et al. Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway. Journal of Translational Medicine. 2015 Jan 15;1-2. https://doi.org/10.1186/1479-5876-13-S1-P5

@article{6a57dbc2bfd04ab6aef912b2eda16e25,

title = "Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway",

author = "Simona Caporali and Ester Alvino and Adriana Amaro and Lacal, {Pedro Miguel} and Lauretta Levati and Atzori, {Maria Grazia} and Cappellini, {Gian Carlo Antonini} and Federica Ruffini and Enzo Bonmassar and Ulrich Pfeffer and Stefania D'Atri",

year = "2015",

month = jan,

day = "15",

doi = "10.1186/1479-5876-13-S1-P5",

language = "English",

pages = "1--2",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway

AU - Caporali, Simona

AU - Alvino, Ester

AU - Amaro, Adriana

AU - Lacal, Pedro Miguel

AU - Levati, Lauretta

AU - Atzori, Maria Grazia

AU - Cappellini, Gian Carlo Antonini

AU - Ruffini, Federica

AU - Bonmassar, Enzo

AU - Pfeffer, Ulrich

AU - D'Atri, Stefania

PY - 2015/1/15

Y1 - 2015/1/15

UR - http://www.scopus.com/inward/record.url?scp=84928711965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928711965&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-13-S1-P5

DO - 10.1186/1479-5876-13-S1-P5

M3 - Article

SP - 1

EP - 2

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this